What Envoy Medical Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 6 |
| Sells | 0 | 0 |
| Total trades | 0 | 8 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 8 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Lucas Brent T. | Chief Executive Officer | May 29 | Grant / award · A | +32,856 | $0.60 | +$19.7K | 329,946 |
| Lucas Brent T. | Chief Executive Officer | Feb 12 | Open-market buy · P | +62,500 | $0.40 | +$25K | 297,090 |
| Potashnick Robert | Interim CFO | Feb 12 | Open-market buy · P | +212,500 | $0.40 | +$85K | 212,500 |
| Patel Mona Chetan | Director | Feb 12 | Open-market buy · P | +312,500 | $0.40 | +$125K | 332,500 |
| Brynelsen Charles | Director | Feb 12 | Open-market buy · P | +1,000,000 | $0.40 | +$400K | 1,050,000 |
| Taylor Glen A | 10% owner | Feb 12 | Open-market buy · P | +18,750,000 | $0.40 | +$7.5M | 21,703,607 |
| Kantor Susan | Director | Feb 12 | Open-market buy · P | +96,150 | $0.40 | +$38.5K | 174,037 |
| Lucas Brent T. | Chief Executive Officer | Nov 28 | Grant / award · A | +18,105 | $0.71 | +$12.9K | 234,590 |
| Patel Mona Chetan | Director | Jun 11 | Open-market buy · P | +2,500 | $1.47 | +$3.68K | 20,000 |
| Patel Mona Chetan | Director | Jun 06 | Open-market buy · P | +10,000 | $1.46 | +$14.6K | 17,500 |
| Lucas Brent T. | Chief Executive Officer | May 30 | Grant / award · A | +7,742 | $1.29 | +$10K | 216,485 |
| Brynelsen Charles | Director | May 27 | Open-market buy · P | +35,000 | $1.65 | +$57.7K | 50,000 |
| Brynelsen Charles | Director | May 23 | Open-market buy · P | +13,000 | $1.64 | +$21.4K | 15,000 |
| Brynelsen Charles | Director | May 22 | Open-market buy · P | +2,000 | $1.68 | +$3.37K | 2,000 |
| Anzu Spac Gp I Llc | 10% owner | Dec 23 | Other Transaction · J | −2,028,986 | — | — | 0 |
| Kantor Susan | Director | Dec 23 | Other Transaction · J | +34,705 | — | — | 77,887 |
| Anzu Spac Gp I Llc | 10% owner | Dec 20 | Derivative Conversion · C | +1,028,986 | — | — | 2,028,986 |
| Lucas Brent T. | Chief Executive Officer | Nov 30 | Grant / award · A | +5,165 | $1.94 | +$10K | 208,743 |
| Patel Mona Chetan | Director | Nov 20 | Open-market buy · P | +2,500 | $2.28 | +$5.7K | 7,500 |
| Anzu Spac Gp I Llc | 10% owner | Nov 19 | Other Transaction · J | −1,000,000 | — | — | 1,000,000 |
Loading...
